Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 280

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 280
---
    )

    Weighted average shares outstanding, basic and diluted

    35,929,446

    38,793,018

The accompanying notes are an integral part of these financial statements. 

100

HCW Biologics Inc.

Statements of Changes in Stockholders’ Equity (Deficit)

    Stockholders’ Equity (Deficit)

    Common Stock

    AdditionalPaid-In

    Accumulated

    TotalStockholders’

    Shares

    Amount

    Capital

    Deficit

    Equity (Deficit)

    Balance, January 1, 2023

    35,876,440

    $
    3,588

    $
    82,962,964

    $
    (45,538,046
    )
     
    $
    37,428,506

    Issuance of Class A   Common Stock upon   exercise of stock options

    148,664

    15

    23,724

    —

    23,739

    Stock-based compensation

    —

    —

    1,003,749

    —

    1,003,749

    Net loss

    —

    —

    —

    (24,994,277
    )

    (24,994,277
    )

    Balance, December 31, 2023

    36,025,104

    $
    3,603

    $
    83,990,437

    $
    (70,532,323
    )
     
    $
    13,461,717

    Issuance of    Common Stock upon exercise of stock options

    13,473

    1

    2,443

    —

    2,444

    Issuance of    Common Stock upon equity subscription

    1,785,718

    178

    2,499,827

    —

    2,500,005

    Issuance of    Common Stock

    4,160,000

    416

    2,452,249

    —

    2,452,665

    Issuance of warrants

    —

    —

    4,465,589

    —

    4,465,589

    Exercise of pre-funded warrants

    2,557,000

    256

    —

    —

    256